Variant report
Variant | nsv963585 |
---|---|
Chromosome Location | chr4:9797896-9802611 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EBF1 | chr4:9802592-9802691 | GM12878 | blood: | n/a | n/a |
2 | FOSL2 | chr4:9798259-9798665 | HepG2 | liver: | n/a | n/a |
3 | JUND | chr4:9798435-9798611 | HepG2 | liver: | n/a | n/a |
4 | MAX | chr4:9802549-9802884 | NB4 | blood: | n/a | chr4:9802698-9802709 chr4:9802710-9802720 chr4:9802710-9802723 chr4:9802712-9802721 chr4:9802697-9802707 chr4:9802711-9802722 chr4:9802703-9802719 |
5 | MXI1 | chr4:9802602-9802819 | GM12878 | blood: | n/a | chr4:9802711-9802720 chr4:9802713-9802722 |
6 | POLR2A | chr4:9798851-9798894 | HepG2 | liver: | n/a | n/a |
7 | POLR2A | chr4:9801634-9801856 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr4:9797631-9797972 | HepG2 | liver: | n/a | n/a |
9 | POLR2A | chr4:9802498-9802866 | HepG2 | liver: | n/a | n/a |
10 | POLR2A | chr4:9799873-9800006 | HepG2 | liver: | n/a | n/a |
11 | POLR2A | chr4:9800628-9800787 | HepG2 | liver: | n/a | n/a |
12 | RFX5 | chr4:9802603-9802631 | GM12878 | blood: | n/a | n/a |
13 | STAT3 | chr4:9800257-9800457 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | USF1 | chr4:9798434-9798586 | HepG2 | liver: | n/a | chr4:9798542-9798553 |
15 | USF2 | chr4:9802552-9802886 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP154 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141183770 | chr4:9797916-9797917 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184387875 | chr4:9797919-9797920 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs552068620 | chr4:9798015-9798016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556255403 | chr4:9798027-9798028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189070632 | chr4:9798030-9798031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146955774 | chr4:9798079-9798080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559976332 | chr4:9798085-9798086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2139240 | chr4:9798092-9798093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181452584 | chr4:9798098-9798099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138052838 | chr4:9798126-9798127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113406918 | chr4:9798139-9798140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550775065 | chr4:9798164-9798165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569420851 | chr4:9798179-9798180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377529549 | chr4:9798196-9798197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2867389 | chr4:9798201-9798202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554272228 | chr4:9798220-9798221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533354134 | chr4:9798222-9798223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2867390 | chr4:9798237-9798238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2867391 | chr4:9798246-9798247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2867392 | chr4:9798248-9798249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185646091 | chr4:9798257-9798258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3060762 | chr4:9798260-9798261 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs567121521 | chr4:9798290-9798291 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs10015812 | chr4:9798316-9798317 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs377537223 | chr4:9798354-9798355 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs555892702 | chr4:9798372-9798373 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs150463413 | chr4:9798395-9798396 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs138311708 | chr4:9798519-9798520 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs58691214 | chr4:9798557-9798558 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs149644486 | chr4:9798566-9798567 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs577330300 | chr4:9798569-9798570 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs544559200 | chr4:9798597-9798598 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs61020282 | chr4:9798604-9798605 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs6449000 | chr4:9798612-9798613 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs35800794 | chr4:9798645-9798646 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs555175537 | chr4:9798646-9798647 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs367672511 | chr4:9798651-9798652 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs547597979 | chr4:9798665-9798666 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs140023275 | chr4:9798750-9798751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542542561 | chr4:9798773-9798774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61121804 | chr4:9798777-9798778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141989960 | chr4:9798802-9798803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543640806 | chr4:9798857-9798858 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs146328952 | chr4:9798883-9798884 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs370585682 | chr4:9798904-9798905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191376363 | chr4:9799000-9799001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180888025 | chr4:9799005-9799006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566885270 | chr4:9799032-9799033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1850738 | chr4:9799134-9799135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185979058 | chr4:9799137-9799138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autosomal-dominant microtia | 18179897 | CNVD |
Glioma | 17123091 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Breast cancer | 17133270 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neuroblastoma | 20406844 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Sinonasal adenocarcinoma | 21360264 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:9794400-9798000 | Weak transcription | HMEC | breast |
2 | chr4:9794600-9805800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr4:9794600-9812600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:9797200-9806400 | Weak transcription | HepG2 | liver |
5 | chr4:9798200-9799200 | Enhancers | HMEC | breast |
6 | chr4:9798800-9815000 | Weak transcription | Lung | lung |
7 | chr4:9799200-9802000 | Weak transcription | Liver | Liver |
8 | chr4:9799200-9819600 | Weak transcription | HMEC | breast |
9 | chr4:9802400-9803400 | Enhancers | Thymus | Thymus |
10 | chr4:9802600-9803800 | Enhancers | Fetal Thymus | thymus |